ALKBH5 and familial pancreatic carcinoma: Emerging evidence has revealed that the aberrant expression of m6A‐associated enzymes, such as ALKBH5, may lead to tumourigenesis, including lung cancer, pancreatic cancer and hepatocellular carcinoma, and these enzymes are promising therapeutic targets.15, 16, 17, 18, 19